Are men with favorable intermediate-risk prostate cancer candidates for active surveillance?

被引：0
|
作者：
Raldow, Ann Caroline
Zhang, Danjie
Chen, Ming-Hui
Braccioforte, Michelle H.
Moran, Brian Joseph
D'Amico, Anthony Victor
机构：
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Univ Connecticut, Storrs, CT USA
[3] Prostate Canc Fdn Chicago, Westmont, IL USA
[4] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.82
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
82
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic Value of the Intermediate-risk Feature in Men with Favorable Intermediate-risk Prostate Cancer: Implications for Active Surveillance
    Sherer, Michael, V
    Leonard, Austin J.
    Nelson, Tyler J.
    Guram, Kripa
    De Moraes, Gustavo Rodrigues
    Javier-Desloges, Juan
    Kane, Christopher
    McKay, Rana R.
    Rose, Brent S.
    Bagrodia, Aditya
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 50 : 61 - 67
  • [2] Identifying intermediate-risk candidates for active surveillance of prostate cancer
    Savdie, Richard
    Aning, Jonathan
    So, Alan I.
    Black, Peter C.
    Gleave, Martin E.
    Goldenberg, S. Larry
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 605.e1 - 605.e8
  • [3] Risk Group and Death From Prostate Cancer Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer
    Raldow, Ann C.
    Zhang, Danjie
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian J.
    D'Amico, Anthony V.
    JAMA ONCOLOGY, 2015, 1 (03) : 334 - 340
  • [4] Outcomes for Men with Intermediate-risk Prostate Cancer on Active Surveillance
    Courtney, P. T.
    Deka, R.
    Cherry, D. R.
    Nelson, T. J.
    Luterstein, E.
    Salans, M. A.
    Yip, A. T. T.
    Nalawade, V.
    Parsons, J. K.
    Kader, K.
    Stewart, T. F.
    Rose, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S121 - S122
  • [5] Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer
    Diven, Marshall A.
    Tshering, Lhaden
    Ma, Xiaoyue
    Hu, Jim C.
    Barbieri, Christopher
    McClure, Timothy
    Nagar, Himanshu
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [6] Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer
    Cooperberg, Matthew R.
    Cowan, Janet E.
    Hilton, Joan F.
    Reese, Adam C.
    Zaid, Harras B.
    Porten, Sima P.
    Shinohara, Katsuto
    Meng, Maxwell V.
    Greene, Kirsten L.
    Carroll, Peter R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) : 228 - 234
  • [7] Re: Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-risk Prostate Cancer
    Gandaglia, Giorgio
    Briganti, Alberto
    Montorsi, Francesco
    EUROPEAN UROLOGY, 2016, 69 (02) : 370 - 370
  • [8] Re: Risk Group and Death from Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-Risk Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2016, 196 (02): : 412 - 413
  • [9] Identification of Pathologically Favorable Disease in Intermediate-Risk Prostate Cancer Patients: Implications for Active Surveillance Candidates Selection
    Gandaglia, Giorgio
    Schiffmann, Jonas
    Schlomm, Thorsten
    Fossati, Nicola
    Moschini, Marco
    Suardi, Nazareno
    Chun, Felix K. H.
    Montorsi, Francesco
    Graefen, Markus
    Briganti, Alberto
    PROSTATE, 2015, 75 (13): : 1484 - 1491
  • [10] Active surveillance in intermediate-risk prostate cancer
    Klotz, Laurence
    BJU INTERNATIONAL, 2020, 125 (03) : 346 - 354
12345